Laurus Labs Ltd. (LAURUSLABS) Share Price Hits Fresh 52-Week High
- August 4, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Ltd. Share Price reached a fresh 52-week high of Rs 1,840.45, marking a 1.35% rise today. The market cap stands at Rs 98,126.1 Cr.
Laurus Labs Ltd. Share Price has achieved a fresh 52-week high, reaching Rs 1,840.45. The stock opened at Rs 1,811 and closed at Rs 1,835.5, reflecting a 1.35% increase from the previous close of Rs 1,811. With a market capitalisation of Rs 98,126.1 Cr, this milestone highlights the stock’s current momentum in the market. The turnover for the day was Rs 7.31 Cr, with a trading volume of 39,799 shares, indicating active participation from investors. This development positions Laurus Labs Ltd. as a focal point for market watchers, given its significant rise in share price.
Laurus Labs Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,835.5 |
| Previous Close | Rs 1,811 |
| Today's Change | +Rs 24.5 (+1.35%) |
| Day Open | Rs 1,811 |
| Fresh 52-Week High | Rs 1,840.45 |
| Day Low | Rs 1,808.15 |
| Current Volume | 39,799 |
| Turnover | Rs 7.31 crore |
| Market Capitalisation | Rs 98,126.1 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,835.5. versus the previous close of Rs 1,811, a rise of 1.35%. The stock opened at Rs 1,811, reached Rs 1,840.45, touched Rs 1,808.15. Reported volume was 39,799.
Today, Laurus Labs Ltd. Share Price opened at Rs 1,811 and reached a high of Rs 1,840.45, setting a new 52-week peak. The stock experienced a low of Rs 1,808.15 before closing at Rs 1,835.5, up by Rs 24.5 or 1.35% from the previous close. The day’s turnover was Rs 7.31 Cr, with a volume of 39,799 shares, indicating robust market activity. This price action reflects investor interest and positions the stock for further analysis in terms of technical and fundamental aspects.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 98,126.1 crore |
| P/E Ratio | 39.39x |
| P/B Ratio | 7.98x |
| ROE | 28.21% |
| ROCE | 26.35% |
Laurus Labs Ltd. was valued at a P/E ratio of 39.39x, a P/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.39x |
| Benchmark Median P/E | 20.89x |
| Benchmark Average P/E | 73.74x |
| Benchmark P/E Range | 0x to 3,364.06x |
| Company P/B Ratio | 7.98x |
| Benchmark Median P/B | 1.9x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 98,126.1 crore |
| Benchmark Median Market Cap | Rs 139.24 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.39 | 7.98 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 62.88 | 9.95 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,421.1 | 34.54 | 6.99 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,416.82 | 171.93 | 3.18 | 13.9 | 12.97 |
| Hester Biosciences Ltd. | HESTERBIO | 2,111.45 | 15.25 | 4.57 | 16.17 | 14.12 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 98,126.1 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs Ltd.
- Fresh 52-week high at Rs 1,840.45, indicating strong price momentum.
- Robust financial metrics with high ROE and ROCE.
- Premium valuation compared to sector medians.
- Significant market capitalisation within the healthcare sector.
About Laurus Labs Ltd.
Laurus Labs Ltd. operates in the healthcare sector, focusing on pharmaceuticals and biotechnology. The company is known for its active pharmaceutical ingredients (APIs), formulations, and custom synthesis services. With a strong presence in the healthcare industry, Laurus Labs Ltd. continues to expand its product offerings and market reach, contributing to its robust financial performance and market leadership.
Track Laurus Labs Ltd. Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Laurus Labs Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive investment analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Laurus Labs Ltd.?
Ans. The current share price of Laurus Labs Ltd. is Rs 1,835.5, reflecting a 1.35% increase from the previous close of Rs 1,811. The stock moved 1.35% during the session. The intraday range extended from Rs 1,808.15 to Rs 1,840.45.
What is the market capitalisation of Laurus Labs Ltd.?
Ans. Laurus Labs Ltd. has a market capitalisation of Rs 98,126.1 Cr, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.39x.
How does Laurus Labs Ltd.'s P/E ratio compare to the sector median?
Ans. Laurus Labs Ltd.'s P/E ratio of 39.39 is higher than the sector median of 20.89, indicating a premium valuation. The company trades at a P/E ratio of 39.39x. Its P/B ratio is 7.98x.
What are Laurus Labs Ltd.'s ROE and ROCE?
Ans. Laurus Labs Ltd. has an ROE of 28.21% and a ROCE of 26.35%, showcasing strong profitability and efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.
What is the 52-week high of Laurus Labs Ltd.?
Ans. The 52-week high of Laurus Labs Ltd. is Rs 1,840.45, achieved recently, indicating strong market momentum. The stock moved 1.35% during the session. The intraday range extended from Rs 1,808.15 to Rs 1,840.45.
How does Laurus Labs Ltd.'s market cap compare to its peers?
Ans. Laurus Labs Ltd.'s market cap of Rs 98,126.1 Cr is significantly higher than its peers, such as Kwality Pharmaceuticals Ltd. and Beta Drugs Ltd. The company operates in the Healthcare sector.
What is Laurus Labs Ltd.'s P/B ratio?
Ans. Laurus Labs Ltd. has a P/B ratio of 7.98, reflecting its valuation relative to its book value. The company trades at a P/E ratio of 39.39x. Its P/B ratio is 7.98x.
